Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6671685

O=C(O)C(F)(F)F.O=C(O)CC(NC(=O)CNC(=O)CCCCNc1ccccn1)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ITGAV P06756 20/20 0.82
ITGB3 P05106 19/20 0.82
ITGA2B P08514 5/20 0.82
ITGB6 P18564 4/20 0.82
ITGB5 P18084 3/20 0.82
ITGB1 P05556 1/20 0.61
ITGA5 P08648 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6670261 0.97 ITGAV (0.78) ITGAVITGB3ITGA2BITGB6ITGB5
Trifluoroacetic Acid SCHEMBL6667521 0.96 ITGAV (0.90) ITGAVITGB3ITGA2BITGB6ITGB5
SCHEMBL6667621 0.96 ITGAV (0.90) ITGAVITGB3ITGA2BITGB6ITGB5
SCHEMBL7171319 0.95 ITGAV (0.88) ITGAVITGB3ITGA2BITGB6ITGB5
SCHEMBL7171300 0.95 ITGAV (0.88) ITGAVITGB3ITGA2BITGB6ITGB5
Trifluoroacetic Acid SCHEMBL6668715 0.93 ITGAV (0.85) ITGAVITGB3ITGA2BITGB6ITGB5
SCHEMBL6668542 0.93 ITGAV (0.84) ITGAVITGB3ITGA2BITGB6ITGB5
Trifluoroacetic Acid SCHEMBL6669938 0.93 ITGAV (0.73) ITGAVITGB3ITGA2BITGB6ITGB5
Trifluoroacetic Acid SCHEMBL6668745 0.93 ITGAV (0.79) ITGAVITGB3ITGA2BITGB6ITGB5
Trifluoroacetic Acid SCHEMBL7172263 0.93 ITGAV (0.81) ITGAVITGB3ITGA2BITGB6ITGB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1153014-B1 BETA-ALANINE DERIVATIVES MERCK PATENT GMBH (DE) 2004-09-22 EP disclosed
US-6576637-B1 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, MERCK PATENT GMBH (DE) 2003-06-10 US disclosed